Lucid Diligence Brief - BioPharma

Bayer Completes Perfuse Therapeutics Acquisition for PER-001 | Lucid Diligence Brief

Bayer has closed its acquisition of Perfuse Therapeutics, securing full rights…


Lucid Diligence Brief - Tech

Merck and Protillion Biosciences Collaboration Examined | Lucid Diligence Brief

Merck and Protillion partner on AI protein design. Assess milestones, platform…


LucidWargames_simulation

In Vivo CAR-T: Stress-Testing the Lilly–Kelonia Deal with AI-Powered Wargaming

Why the Lilly–Kelonia Deal Matters for In Vivo CAR-T Download the…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: InSilico Medicine and Lilly global partnership

Lucid Diligence Brief: InSilico Medicine and Lilly global partnership…


Privacy Preference Center